Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes
Top Cited Papers
- 22 July 2013
- journal article
- research article
- Published by Elsevier BV in Diabetes & Metabolism
- Vol. 39 (5), 445-453
- https://doi.org/10.1016/j.diabet.2013.05.006
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Standards of Medical Care in Diabetes—2012Diabetes Care, 2011
- New injection recommendations for patients with diabetesDiabetes & Metabolism, 2010
- Results and analysis of the 2008–2009 Insulin Injection Technique Questionnaire surveyJournal of Diabetes, 2010
- Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literatureExpert Opinion on Drug Safety, 2009
- Lipohypertrophy: does it matter in daily life? A study using a continuous glucose monitoring systemDiabetes, Obesity and Metabolism, 2009
- Insulin AdministrationDiabetes Care, 2004
- Poor glycaemic control caused by insulin induced lipohypertrophyBMJ, 2003
- Factors related to lipohypertrophy in insulin‐treated diabetic patients: role of educational interventionPractical Diabetes International, 1998
- Morphology of Palpably Abnormal Injection Sites and Effects on Absorption of Isophane(NPH) InsulinDiabetic Medicine, 1990
- The Variability of the Absorption of Subcutaneously Injected Insulin: Effect of Injection Technique and Relation with BrittlenessDiabetic Medicine, 1990